glp 1 with blue cross blue shield GLP-1 Drugs Could Raise Employer Health Premiums Anthem Blue Cross Blue Shield

Food and Drug Administration has recently identified drug-induced alopecia (hair loss) as an adverse event for patients taking GLP-1 medications

Neglecting your sleep hygienethat is, habits and choices that influence the quality and consistency of your sleepis essential, whether youre taking semaglutide or not

Study approval

Preliminary data suggest that tirzepatide, by improving weight and metabolic status, may enhance patient adherence to CPAP therapy and amplify overall therapeutic outcomes (53, 54)

"Triple Hormone Receptor Agonist Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease: a randomised, double-blind, placebo-controlled, phase 2a trial." Nature Medicine , 2024

Tirzepatide may also affect heart rate